chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Pericarditis
Clinical narrative: acute pericarditis; Patient developed chest pain.; This is a spontaneous report from a contactable physician. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), dose 1 via intramuscular route, administered in arm left on 21Apr2021 at 12:00 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient did not diagnose with COVID-19. On 26Apr2021 at 03:00, the patient developed chest pain and she was taken to emergency department. She was admitted to observation. Electrocardiogram (EKG) changes and lab results consistent with acute pericarditis. The events resulted in emergency room visit or urgent care and physician office visit. The patient underwent lab tests and procedures which included PCR covid test with nasal swab on 26Apr2021 and result was negative. The patient received treatment included intravenous fluids, Toradol, indomethacin, and colchicine for the events. The outcome of the events was resolving. Batch/lot was unknown as not provided to reporter at the time of report completion.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the temporal relationship, A possible contributory role of the suspect product to the development of Chest pain and Acute Pericarditis cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Electrocardiogram, Investigation, Pericarditis, Polymerase chain reaction
Clinical narrative: acute pericarditis; Patient developed chest pain.; This is a spontaneous report from a contactable physician. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), dose 1 via intramuscular route, administered in arm left on 21Apr2021 at 12:00 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient did not diagnose with COVID-19. On 26Apr2021 at 03:00, the patient developed chest pain and she was taken to emergency department. She was admitted to observation. Electrocardiogram (EKG) changes and lab results consistent with acute pericarditis. The events resulted in emergency room visit or urgent care and physician office visit. The patient underwent lab tests and procedures which included PCR covid test with nasal swab on 26Apr2021 and result was negative. The patient received treatment included intravenous fluids, Toradol, indomethacin, and colchicine for the events. The outcome of the events was resolving. Batch/lot was unknown as not provided to reporter at the time of report completion.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the temporal relationship, A possible contributory role of the suspect product to the development of Chest pain and Acute Pericarditis cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Blood test, Catheterisation cardiac abnormal, Chest pain, Computerised tomogram thorax abnormal
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 08:15 (Batch/Lot Number: EW0171) (at age 40 years old) as single dose for covid-19 immunisation. Medical history included high blood pressure, high cholesterol, carpel tunnel, absent vas deferens, all from unspecified dates. No COVID prior to vaccination. He underwent Covid test post vaccination (nasal swab) on 29Apr2021 with negative result. The patient's concomitant medications included unspecified prescribed and store-bought medications. No other vaccines in four weeks. On 28Apr2021 22:00, the patient experienced chest pains and shortness of breath testing of EKGs, echo, CT scan, and cardiac cath show- NStemi heart attack showing from damage to heart caused by blood clot. No problems with arteries or existing with heart. Also, lower lobe of left lung shows collapsed. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The events were considered serious: hospitalization (2 days), life threatening illness (immediate risk of death from the event), disability or permanent damage. Treatment included blood thinners- apixaban (ELIQUIS) and metoprolol. The patient was recovering from the events.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Electrocardiogram abnormal, Heart injury, Intensive care
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 08:15 (Batch/Lot Number: EW0171) (at age 40 years old) as single dose for covid-19 immunisation. Medical history included high blood pressure, high cholesterol, carpel tunnel, absent vas deferens, all from unspecified dates. No COVID prior to vaccination. He underwent Covid test post vaccination (nasal swab) on 29Apr2021 with negative result. The patient's concomitant medications included unspecified prescribed and store-bought medications. No other vaccines in four weeks. On 28Apr2021 22:00, the patient experienced chest pains and shortness of breath testing of EKGs, echo, CT scan, and cardiac cath show- NStemi heart attack showing from damage to heart caused by blood clot. No problems with arteries or existing with heart. Also, lower lobe of left lung shows collapsed. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The events were considered serious: hospitalization (2 days), life threatening illness (immediate risk of death from the event), disability or permanent damage. Treatment included blood thinners- apixaban (ELIQUIS) and metoprolol. The patient was recovering from the events.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Intracardiac thrombus, Lymphadenopathy, Pneumothorax, Pulmonary mass
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 08:15 (Batch/Lot Number: EW0171) (at age 40 years old) as single dose for covid-19 immunisation. Medical history included high blood pressure, high cholesterol, carpel tunnel, absent vas deferens, all from unspecified dates. No COVID prior to vaccination. He underwent Covid test post vaccination (nasal swab) on 29Apr2021 with negative result. The patient's concomitant medications included unspecified prescribed and store-bought medications. No other vaccines in four weeks. On 28Apr2021 22:00, the patient experienced chest pains and shortness of breath testing of EKGs, echo, CT scan, and cardiac cath show- NStemi heart attack showing from damage to heart caused by blood clot. No problems with arteries or existing with heart. Also, lower lobe of left lung shows collapsed. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The events were considered serious: hospitalization (2 days), life threatening illness (immediate risk of death from the event), disability or permanent damage. Treatment included blood thinners- apixaban (ELIQUIS) and metoprolol. The patient was recovering from the events.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Catheterisation cardiac, Chest pain, Computerised tomogram, Dyspnoea
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 08:15 (Batch/Lot Number: EW0171) (at age 40 years old) as single dose for covid-19 immunisation. Medical history included high blood pressure, high cholesterol, carpel tunnel, absent vas deferens, all from unspecified dates. No COVID prior to vaccination. He underwent Covid test post vaccination (nasal swab) on 29Apr2021 with negative result. The patient's concomitant medications included unspecified prescribed and store-bought medications. No other vaccines in four weeks. On 28Apr2021 22:00, the patient experienced chest pains and shortness of breath testing of EKGs, echo, CT scan, and cardiac cath show- NStemi heart attack showing from damage to heart caused by blood clot. No problems with arteries or existing with heart. Also, lower lobe of left lung shows collapsed. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The events were considered serious: hospitalization (2 days), life threatening illness (immediate risk of death from the event), disability or permanent damage. Treatment included blood thinners- apixaban (ELIQUIS) and metoprolol. The patient was recovering from the events.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram, Electrocardiogram, Pneumothorax, SARS-CoV-2 test, Thrombosis
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 08:15 (Batch/Lot Number: EW0171) (at age 40 years old) as single dose for covid-19 immunisation. Medical history included high blood pressure, high cholesterol, carpel tunnel, absent vas deferens, all from unspecified dates. No COVID prior to vaccination. He underwent Covid test post vaccination (nasal swab) on 29Apr2021 with negative result. The patient's concomitant medications included unspecified prescribed and store-bought medications. No other vaccines in four weeks. On 28Apr2021 22:00, the patient experienced chest pains and shortness of breath testing of EKGs, echo, CT scan, and cardiac cath show- NStemi heart attack showing from damage to heart caused by blood clot. No problems with arteries or existing with heart. Also, lower lobe of left lung shows collapsed. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The events were considered serious: hospitalization (2 days), life threatening illness (immediate risk of death from the event), disability or permanent damage. Treatment included blood thinners- apixaban (ELIQUIS) and metoprolol. The patient was recovering from the events.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Multisystem inflammatory syndrome in children
Clinical narrative: MIS-C; COVID-19 nasal swab PCR test that was positive; 12-year-old patient received the first dose of BNT162B2; This is a spontaneous report from a contactable pharmacist. A non-pregnant 12-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8735), intramuscular, on 14Apr2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. Prior to vaccination, the patient diagnosed was not with COVID-19. On 24Apr2021, the patient experienced multisystem inflammatory syndrome in children (MIS-C) that resulted in hospitalization from Apr2021 to an unspecified date in 2021 (for 9 days) and considered serious as life-threatening illness (immediate risk of death from the event). Treatment was received for the adverse event including IVIG and steroids. After the vaccination, the patient underwent COVID-19 nasal swab polymerase chain reaction (PCR) test that was positive on 24Apr2021 and negative on 28Apr2021. The patient was recovering from "MIS-C". The patient recovered from the other event on 28Apr2021.; Sender's Comments: Based on the available information, and on a plausible temporal association, a reasonable possibility cannot be excluded that the suspect drug BNT162B2 (Pfizer-BioNTech COVID-19 vaccine)  contributed to the occurrence of the serious event Multisystem inflammatory syndrome in children (MIS-C). The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Multisystem inflammatory syndrome in children, Product administered to patient of inappropriate age, SARS-CoV-2 test
Clinical narrative: MIS-C; COVID-19 nasal swab PCR test that was positive; 12-year-old patient received the first dose of BNT162B2; This is a spontaneous report from a contactable pharmacist. A non-pregnant 12-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8735), intramuscular, on 14Apr2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. Prior to vaccination, the patient diagnosed was not with COVID-19. On 24Apr2021, the patient experienced multisystem inflammatory syndrome in children (MIS-C) that resulted in hospitalization from Apr2021 to an unspecified date in 2021 (for 9 days) and considered serious as life-threatening illness (immediate risk of death from the event). Treatment was received for the adverse event including IVIG and steroids. After the vaccination, the patient underwent COVID-19 nasal swab polymerase chain reaction (PCR) test that was positive on 24Apr2021 and negative on 28Apr2021. The patient was recovering from "MIS-C". The patient recovered from the other event on 28Apr2021.; Sender's Comments: Based on the available information, and on a plausible temporal association, a reasonable possibility cannot be excluded that the suspect drug BNT162B2 (Pfizer-BioNTech COVID-19 vaccine)  contributed to the occurrence of the serious event Multisystem inflammatory syndrome in children (MIS-C). The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Headache, Hemianopia homonymous
Clinical narrative: 2 days of headache, encephaloapthy, L arm weakness + paresthesia. CT head found Cerebral venous sinus thrombosis with intraparenchymal hemorrhage transformation and developed seizures. currently on therapeutic heparin drip, lacosamide, and keppra
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hemiparesis, Laboratory test normal, Neurologic neglect syndrome
Clinical narrative: 2 days of headache, encephaloapthy, L arm weakness + paresthesia. CT head found Cerebral venous sinus thrombosis with intraparenchymal hemorrhage transformation and developed seizures. currently on therapeutic heparin drip, lacosamide, and keppra
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Condition aggravated, Encephalopathy, Haemorrhagic transformation stroke
Clinical narrative: 2 days of headache, encephaloapthy, L arm weakness + paresthesia. CT head found Cerebral venous sinus thrombosis with intraparenchymal hemorrhage transformation and developed seizures. currently on therapeutic heparin drip, lacosamide, and keppra
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Magnetic resonance imaging head, Muscular weakness, Paraesthesia
Clinical narrative: 2 days of headache, encephaloapthy, L arm weakness + paresthesia. CT head found Cerebral venous sinus thrombosis with intraparenchymal hemorrhage transformation and developed seizures. currently on therapeutic heparin drip, lacosamide, and keppra
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Confusional state, Headache, Hemianopia homonymous
Clinical narrative: 2 days of headache, encephaloapthy, L arm weakness + paresthesia. CT head found Cerebral venous sinus thrombosis with intraparenchymal hemorrhage transformation and developed seizures. currently on therapeutic heparin drip, lacosamide, and keppra
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hemiparesis, Intensive care, Migraine, Seizure
Clinical narrative: 2 days of headache, encephaloapthy, L arm weakness + paresthesia. CT head found Cerebral venous sinus thrombosis with intraparenchymal hemorrhage transformation and developed seizures. currently on therapeutic heparin drip, lacosamide, and keppra
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Deep vein thrombosis, Erythema, Heparin-induced thrombocytopenia test positive, Peripheral swelling
Clinical narrative: Blood clots in right arm and lungs. Swollen right arm.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary embolism, Subclavian vein thrombosis
Clinical narrative: Blood clots in right arm and lungs. Swollen right arm.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test normal, Computerised tomogram thorax abnormal, Electrocardiogram normal, Peripheral swelling, Pulmonary thrombosis
Clinical narrative: Blood clots in right arm and lungs. Swollen right arm.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: Blood clots in right arm and lungs. Swollen right arm.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Influenza like illness, Peripheral swelling, Pulmonary thrombosis, Skin discolouration, Thrombosis
Clinical narrative: Blood clots in right arm and lungs. Swollen right arm.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Coordination abnormal, Feeling abnormal
Clinical narrative: MEMORY IMPAIRED; FOGGY FEELING IN HEAD; This spontaneous report received from a patient concerned a 43 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination.The Batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced memory impaired, and foggy feeling in head. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the memory impaired and foggy feeling in head was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Memory impairment
Clinical narrative: MEMORY IMPAIRED; FOGGY FEELING IN HEAD; This spontaneous report received from a patient concerned a 43 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination.The Batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced memory impaired, and foggy feeling in head. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the memory impaired and foggy feeling in head was not reported. This report was non-serious.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood lactic acid increased, Chest X-ray abnormal, Condition aggravated, Headache, Hypoaesthesia
Clinical narrative: Allergic swelling of young and throat; Allergic swelling of young and throat; Shakes; Numbness on right side of face; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 20Apr2021 14:00 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history included allergies to gluten and dairy, covid prior vaccination and Mthfr. There were no concomitant medications. The patient has no other vaccine in four weeks and no other medications in two weeks. The patient experienced shakes, numbness on right side of face and allergic swelling of "young" (as reported) and throat on 20Apr2021 at 22:00. The events were treated with Benadryl. The patient was not tested for covid-19 post vaccination. The outcome of the events was recovered with sequel on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal swelling, Pneumonia, Swollen tongue, Tremor, White blood cell count increased
Clinical narrative: Allergic swelling of young and throat; Allergic swelling of young and throat; Shakes; Numbness on right side of face; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 20Apr2021 14:00 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history included allergies to gluten and dairy, covid prior vaccination and Mthfr. There were no concomitant medications. The patient has no other vaccine in four weeks and no other medications in two weeks. The patient experienced shakes, numbness on right side of face and allergic swelling of "young" (as reported) and throat on 20Apr2021 at 22:00. The events were treated with Benadryl. The patient was not tested for covid-19 post vaccination. The outcome of the events was recovered with sequel on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Pharyngeal swelling, Swollen tongue, Tremor
Clinical narrative: Allergic swelling of young and throat; Allergic swelling of young and throat; Shakes; Numbness on right side of face; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 20Apr2021 14:00 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history included allergies to gluten and dairy, covid prior vaccination and Mthfr. There were no concomitant medications. The patient has no other vaccine in four weeks and no other medications in two weeks. The patient experienced shakes, numbness on right side of face and allergic swelling of "young" (as reported) and throat on 20Apr2021 at 22:00. The events were treated with Benadryl. The patient was not tested for covid-19 post vaccination. The outcome of the events was recovered with sequel on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye movement disorder, Head injury, Headache, Loss of consciousness, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood blister, Blood test, Computerised tomogram, Dysphagia, Laryngoscopy
Clinical narrative: I had a wierd thing happen and am reporting according to the guidance to report even if not certain it is due to Covid vaccine. About 3 weeks after my second dose of Moderna, I developed a small blood blister in my mouth while eating a cheese platter with crackers. The blood blister grew so rapidly, that I soon couldn't talk or swallow. My husband drove me to the urgent care and they called an ambulance.  The urgent care gave me a shot with an epi-pen. The ambulance took me to the hospital where an emergency surgery procedure of soft palate exam with laryngoscopy was performed.  Prior to this, I have had no allergies or reactions to food. This came out of nowhere. The ENT doctor said I may have scratched the roof of my mouth with a cracker but I don't recall doing that. I had no mouth pain prior to this blood blister. I am following up with an allergy doctor next week.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder
Clinical narrative: I had a wierd thing happen and am reporting according to the guidance to report even if not certain it is due to Covid vaccine. About 3 weeks after my second dose of Moderna, I developed a small blood blister in my mouth while eating a cheese platter with crackers. The blood blister grew so rapidly, that I soon couldn't talk or swallow. My husband drove me to the urgent care and they called an ambulance.  The urgent care gave me a shot with an epi-pen. The ambulance took me to the hospital where an emergency surgery procedure of soft palate exam with laryngoscopy was performed.  Prior to this, I have had no allergies or reactions to food. This came out of nowhere. The ENT doctor said I may have scratched the roof of my mouth with a cracker but I don't recall doing that. I had no mouth pain prior to this blood blister. I am following up with an allergy doctor next week.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: 50-year male who received his first dose of the Moderna vaccine today, 05/04/2021 at 10:08am. His observation time ended at 10:23 am. Patient admitted to going thru some trash earlier. Moderna Vaccine, lot #024C21A, Expiration date 05/04/2021. Received in the right deltoid. After one hour, approximately 11:13am, the patient returned to the vaccine site stating he had bilateral lower arm itching with visible rash. The patient reports a history of emphysema, blunt head trauma, and prior history of taking Dilantin. He reports no medication history with last Dilantin dose approximately one year ago. He denies chest pain, shortness of breath, headache, dizziness, difficulty swallowing, cough, facial/mouth swelling, and throat swelling. Vital signs were 108/82, HR 70, SpO2 93%, RR 18. Upper breath sounds diminished. The patient was observed by medical staff for approximately 10 minutes, upon which he wanted to return to his room (#205). The patient received one dose of diphenhydramine 25mg with relief of symptoms. Patient received education on anaphylaxis with strict ER return precautions.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pain, Pyrexia
Clinical narrative: Body ache, nausea, mild fever, light headed
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Injection site began itching, had red appearance, warm to touch, and could visibly see and feel a knot forming at injection site. Rubbed on arm to subside itch, noticed slight pain when pressing on area.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pruritus, Injection site warmth, Vaccination site erythema, Vaccination site nodule
Clinical narrative: Injection site began itching, had red appearance, warm to touch, and could visibly see and feel a knot forming at injection site. Rubbed on arm to subside itch, noticed slight pain when pressing on area.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Feeling abnormal, Nausea, Pain
Clinical narrative: She had no pain from the initial shot but then that night she stated she felt horrible, aches and pains and her cough worsened. a week later she said that the symptoms were just as bad, she was extremely tired also. Nauseated as well. She did not believe that she had a fever.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Pt reported extended nose bleed for 5 days following the vaccine. Enough to soak piles of tissues and was constant.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: High fever (104.5), headache, body ache, chills. He took Tylenol every 6 hours for 48 hours
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature increased, Chills, Headache
Clinical narrative: I got a headache about noon on 4/9. I started shivering at 9 pm. I woke at 11 pm shivering uncontrollably. I took my temperature at 1 am and it was 102 degrees F.  My temp dropped gradually and returned to normal by 12 noon on 4/10. I also had a bad headache. On 4/11 I felt fine but was weak.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Injection site swelling, Periorbital swelling
Clinical narrative: Rash and swelling and redness around the injection site. Swollen painful under eye on one side of face.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient was given Pfizer as 2nd dose. Later, it was shown by patient that he received Moderna as his first dose.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Ear pain, Feeling abnormal, Inflammation, Swelling
Clinical narrative: Tinnitus level 8/10. Bad swelling / inflammation. Brain fog. Diarrhea. Ear pain. Treated with large doses of Antronex with recommendation from Chiropractor.  Antronex helped reduce swelling. Treated sinuses with Xlear nasal spray. Helped reduce swelling. Tinnitus still at level 4/10 after 9 days.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus level 8/10. Bad swelling / inflammation. Brain fog. Diarrhea. Ear pain. Treated with large doses of Antronex with recommendation from Chiropractor.  Antronex helped reduce swelling. Treated sinuses with Xlear nasal spray. Helped reduce swelling. Tinnitus still at level 4/10 after 9 days.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vertigo
Clinical narrative: Extreme vertigo with very, very bad nausea and of-and-on headache. Waited it out without treatment because my doctor and due to them being hacked, I was unable to reach my doctor. I stayed on the couch for approximately 2 days and also slept there, so as to sleep sitting up, as the work vertigo came while I was sleeping in bed. 1st bad vertigo episode: May 4 approx. 3:30 pm.  Next bad vertigo episode May 5 at 6:10 am sleeping in bed with bad nausea. Third/final bad vertigo episode May 6 at 3:20am with bad nausea while sleeping in bed. Vertigo then decreased / leveled off but continued along with nausea until May 6 11:00 pm. May 7, I woke up with no nausea or headache. Very slight vertigo approx. 4 times during May 7.
Age: 54.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pruritus
Clinical narrative: Extreme fatigue Chills Body ache Itchy
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Upper arm pain
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Immediate post-injection reaction, Myalgia, Nausea
Clinical narrative: immediately following injection, , nausea (stayed onsite for 15 min after shot), - the next 48 hours, muscle achiness,  no/low energy, fatigue
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction, Injection site swelling, Rash erythematous
Clinical narrative: Approx 24 hours after receiving the second dose of the Moderna vaccine, a circular, swollen, red rash developed at the injection site. Since then, the rash has continued to grow and is currently 4" in diameter (36 hours post vaccination).
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide, Deep vein thrombosis, Echocardiogram, Full blood count, Metabolic function test
Clinical narrative: Pt developed a very large DVT in his left lower extremity. The symptoms started approximately 10 days after receiving his first Covid vaccine
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound Doppler abnormal
Clinical narrative: Pt developed a very large DVT in his left lower extremity. The symptoms started approximately 10 days after receiving his first Covid vaccine
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Pruritus, Swelling
Clinical narrative: Moderna Arm (delayed sight reaction) swelling and hot to touch with a definitive redness and oval in shape. Has grown 3 x larger over night. Some itching and pain. No medicine taken and not too uncomfortable. On day two of the reaction.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Erectile dysfunction
Clinical narrative: Three days after the shot I had encountered an instance of maintaining an Erection during intercourse. This is the first time ever experiencing such issue. It got much worse in the following weeks. Issue persisted until late April after which I am totally fine.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: ringing in ears
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram, Cough, Dyspnoea, X-ray
Clinical narrative: I developed a cough and shortness of breath until May
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Migraine, Nausea
Clinical narrative: Severe chills and nausea, diarrhea, exhaustion, fatigue, migraine
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: I started to feel injection site pain and a headache approximately 4 hours after the injection. I then went to bed. I woke up at 5 AM and couldn't get back to sleep. I had an extremely severe headache. shaking chills, fever (fluctuated between 101 and 102) and severe fatigue and muscle and joint pain. Muscle and joint pain was primarily in my neck, shoulders, back and chest. It hurt to open my eyes or even move. I had no appetite and wasn't eating or drinking, but I urinated a lot, so I knew I was getting dehydrated. I tried to drink sips of water and managed to keep it down, until 11 PM on the day following the shot, I vomited and became nauseated. I had a hard time sleeping again. I woke up on the second day after the shot with a lingering headache and fatigue, but my fever was gone and I could move more easily. I gradually improved throughout the day. It doesn't sound terrible as I'm reading/writing this, but for about 36 hours; I haven't been that sick since I was a child, I don't think. It made me not want to have a booster shot if it's needed later. If I have to; I'll definitely need to have it on a Friday. I'm so jealous of people who've said they had no side effects or very mild ones. I had to take two days off work. I have to say though that although the side effects were severe and came on fairly quickly; they were also nearly all gone 48 hours after the shot. I felt so awful, it seemed like longer than 36 hours of misery, but in reality it wasn't.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Injection site pain, Myalgia, Nausea, Pyrexia
Clinical narrative: I started to feel injection site pain and a headache approximately 4 hours after the injection. I then went to bed. I woke up at 5 AM and couldn't get back to sleep. I had an extremely severe headache. shaking chills, fever (fluctuated between 101 and 102) and severe fatigue and muscle and joint pain. Muscle and joint pain was primarily in my neck, shoulders, back and chest. It hurt to open my eyes or even move. I had no appetite and wasn't eating or drinking, but I urinated a lot, so I knew I was getting dehydrated. I tried to drink sips of water and managed to keep it down, until 11 PM on the day following the shot, I vomited and became nauseated. I had a hard time sleeping again. I woke up on the second day after the shot with a lingering headache and fatigue, but my fever was gone and I could move more easily. I gradually improved throughout the day. It doesn't sound terrible as I'm reading/writing this, but for about 36 hours; I haven't been that sick since I was a child, I don't think. It made me not want to have a booster shot if it's needed later. If I have to; I'll definitely need to have it on a Friday. I'm so jealous of people who've said they had no side effects or very mild ones. I had to take two days off work. I have to say though that although the side effects were severe and came on fairly quickly; they were also nearly all gone 48 hours after the shot. I felt so awful, it seemed like longer than 36 hours of misery, but in reality it wasn't.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Tremor, Vomiting
Clinical narrative: I started to feel injection site pain and a headache approximately 4 hours after the injection. I then went to bed. I woke up at 5 AM and couldn't get back to sleep. I had an extremely severe headache. shaking chills, fever (fluctuated between 101 and 102) and severe fatigue and muscle and joint pain. Muscle and joint pain was primarily in my neck, shoulders, back and chest. It hurt to open my eyes or even move. I had no appetite and wasn't eating or drinking, but I urinated a lot, so I knew I was getting dehydrated. I tried to drink sips of water and managed to keep it down, until 11 PM on the day following the shot, I vomited and became nauseated. I had a hard time sleeping again. I woke up on the second day after the shot with a lingering headache and fatigue, but my fever was gone and I could move more easily. I gradually improved throughout the day. It doesn't sound terrible as I'm reading/writing this, but for about 36 hours; I haven't been that sick since I was a child, I don't think. It made me not want to have a booster shot if it's needed later. If I have to; I'll definitely need to have it on a Friday. I'm so jealous of people who've said they had no side effects or very mild ones. I had to take two days off work. I have to say though that although the side effects were severe and came on fairly quickly; they were also nearly all gone 48 hours after the shot. I felt so awful, it seemed like longer than 36 hours of misery, but in reality it wasn't.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Vision blurred
Clinical narrative: First one suffered , severe nausea and extreme exhaustion Second dose I suffered abdominal pain on day 2 after injection ,but mostly severe brain "fog" ... difficult to focus, felt unclear.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Anti-cyclic citrullinated peptide antibody, Antinuclear antibody, Antiphospholipid antibodies, Arthralgia, Blood 25-hydroxycholecalciferol
Clinical narrative: Approximately, two weeks after receiving the vaccine, patient presented with severe pain in all joints. Subsequent lab work showed an elevated white count consistent with an immune system response. At the time of this report patient is awaiting further consultation to review subsequent lab work to either exclude or diagnose patient with a possible autoimmune disorder such as lupus or MS, etc. However, current lab work results, while not conclusive, suggest the likely exclusion of those diagnoses. Upon consultation with my healthcare provider further investigation is suggested. It is unclear if the vaccine is a. the cause of original symptoms, b. if diagnosed with another condition, is the vaccine the cause or c. not related at all to the patient's illness.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatine phosphokinase, Blood folate, Blood iron, Blood test, C-reactive protein
Clinical narrative: Approximately, two weeks after receiving the vaccine, patient presented with severe pain in all joints. Subsequent lab work showed an elevated white count consistent with an immune system response. At the time of this report patient is awaiting further consultation to review subsequent lab work to either exclude or diagnose patient with a possible autoimmune disorder such as lupus or MS, etc. However, current lab work results, while not conclusive, suggest the likely exclusion of those diagnoses. Upon consultation with my healthcare provider further investigation is suggested. It is unclear if the vaccine is a. the cause of original symptoms, b. if diagnosed with another condition, is the vaccine the cause or c. not related at all to the patient's illness.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Full blood count, Iron binding capacity total, Metabolic function test, Platelet count
Clinical narrative: Approximately, two weeks after receiving the vaccine, patient presented with severe pain in all joints. Subsequent lab work showed an elevated white count consistent with an immune system response. At the time of this report patient is awaiting further consultation to review subsequent lab work to either exclude or diagnose patient with a possible autoimmune disorder such as lupus or MS, etc. However, current lab work results, while not conclusive, suggest the likely exclusion of those diagnoses. Upon consultation with my healthcare provider further investigation is suggested. It is unclear if the vaccine is a. the cause of original symptoms, b. if diagnosed with another condition, is the vaccine the cause or c. not related at all to the patient's illness.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate, Rheumatoid factor, Serum ferritin, Transferrin, Urine analysis
Clinical narrative: Approximately, two weeks after receiving the vaccine, patient presented with severe pain in all joints. Subsequent lab work showed an elevated white count consistent with an immune system response. At the time of this report patient is awaiting further consultation to review subsequent lab work to either exclude or diagnose patient with a possible autoimmune disorder such as lupus or MS, etc. However, current lab work results, while not conclusive, suggest the likely exclusion of those diagnoses. Upon consultation with my healthcare provider further investigation is suggested. It is unclear if the vaccine is a. the cause of original symptoms, b. if diagnosed with another condition, is the vaccine the cause or c. not related at all to the patient's illness.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Vitamin B12, Vitamin D
Clinical narrative: Approximately, two weeks after receiving the vaccine, patient presented with severe pain in all joints. Subsequent lab work showed an elevated white count consistent with an immune system response. At the time of this report patient is awaiting further consultation to review subsequent lab work to either exclude or diagnose patient with a possible autoimmune disorder such as lupus or MS, etc. However, current lab work results, while not conclusive, suggest the likely exclusion of those diagnoses. Upon consultation with my healthcare provider further investigation is suggested. It is unclear if the vaccine is a. the cause of original symptoms, b. if diagnosed with another condition, is the vaccine the cause or c. not related at all to the patient's illness.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in jaw, Toothache
Clinical narrative: Minor breakthrough jaw pain(twinges like a sensitive tooth pain and not the "electrical" type pain of my TN) but on opposite side-Right side while eating and drinking. Headache a little worse than my "normal" type. Could just be my system dealing with the normal process of getting a vaccine. Not concerned enough at this time to get further testing or a doctor visit.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Pain, Pyrexia
Clinical narrative: Super extreme headache and high fever.  Body ache and weakness.  Took ibuprofen whenever there was extreme pain (approx. 3 times). The pain reduced because of the medicine but it came back once the effect of the medicine subsided.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Pyrexia, Tremor
Clinical narrative: incontrollable shaking, low-grade fever, sore left arm
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: EXTREME TINNITUS
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Influenza like illness, Tinnitus
Clinical narrative: No adverse events after 1st dose. I had very mild flu like symptoms 24 hours after 2nd dose.  Then a week later I began having ringing in my ears.  This has been continuous since that day.
Age: 58.0
Sex: F
Vaccine: UNK
Symptoms: Body temperature increased, Dizziness, Headache, Hyperhidrosis, Nausea
Clinical narrative: Upon receiving the Johnson and Johnson one dose vaccine I felt fine   Waited more than suggested time in the store to assure I would be ok .  I went home , are dinner, watched TV , and went to bed still feeling fine.   I awoke at 2:42 AM sweating, with a pain in one of my legs, pounding headache and nauseated .   The entire day and following day I had 101 fever,  severe headache , was nauseated and dizzy .   On the 3rd day after receiving the vaccine although I had no fever or headache ,  I was still dizzy and nauseated periodically .  By day 4 , all symptoms disappeared with the exception of the dizziness  .  By day 5 , I was still dizzy and developed a moderate headache in the evening.
Age: 58.0
Sex: F
Vaccine: UNK
Symptoms: Pain in extremity
Clinical narrative: Upon receiving the Johnson and Johnson one dose vaccine I felt fine   Waited more than suggested time in the store to assure I would be ok .  I went home , are dinner, watched TV , and went to bed still feeling fine.   I awoke at 2:42 AM sweating, with a pain in one of my legs, pounding headache and nauseated .   The entire day and following day I had 101 fever,  severe headache , was nauseated and dizzy .   On the 3rd day after receiving the vaccine although I had no fever or headache ,  I was still dizzy and nauseated periodically .  By day 4 , all symptoms disappeared with the exception of the dizziness  .  By day 5 , I was still dizzy and developed a moderate headache in the evening.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinninitus
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Amnesia, Aphasia, Chest pain, Chills
Clinical narrative: Lightheaded, slurred speech, difficulty forming or saying words, headache, chest pain, shortness of breath, fatigue, couldn't remember how to do things at work that I do everyday, abdominal pain, chills and fever.